Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.

Biotechnology

Leap Therapeutics

Leap Therapeutics' headquarters in Cambridge, MA, United States

Douglas Onsi

Gus Lawlor

Jason Baum

Mark O'Mahony

Cyndi Sirard

Christopher Mirabelli

Research and Scientific Team

Clinical Development Team

Manufacturing and Operations Team

Data Management and Analysis Team

Regulatory Affairs and Quality Team

Leadership Team

Leap Therapeutics

Org chart

Board & advisors

Teams